Eye Sonix is a medical device company created with the purpose of developing a new method of treating open angle glaucoma. We are in early laboratory testing at this time. We have a device which is patent pending with the application number #20080051681 As we move forward more information will be placed on the Website.
It has been reported in the literature that cataract surgery using ultrasound has an unintended but beneficial effect on the intraocular pressure of those patients that have coexisting glaucoma. In addition reports document that lasers, when used to treat glaucoma, trigger specific biochemical pathways of cytokines.
Eyesonix is developing prototypes to harness the effects of ultrasound to trigger a similar cytokine effect as is seen in laser glaucoma therapy and to utilize the inherent sonomechanical effect of ultrasound.
We have now been awarded the patent for our treatment method #7909781 dated March 22, 2011.
The early clinical work is supporting the concept with early data comparable to laser treatment.
2650 Elm Ave #108 LONG BEACH, CA90806 ph: 562 427 5409 fax: 562 426 6321 dschwartz@eyesonix.com